Top Pharmaceuticals companies in United States by Free Cash Flow

This ranking features the top 646 Pharmaceuticals companies in United States ranked by Free Cash Flow, totalling a Free Cash Flow of USD 138.16 B, for January 15, 2025.

United States

Pharmaceuticals

#	Name	Free Cash Flow	Reported Date	Stock Price	Change	Country
1	Coherent, Inc. 1 COHR	USD 61.06 B	Sept. 30, 2024	USD 93.00	1.03%	United States
2	Nutex Health, Inc. 2 NUTX	USD 23.11 B	Sept. 30, 2024	USD 32.00	4.03%	United States
3	Johnson & Johnson 3 JNJ	USD 19.50 B	Sept. 29, 2024	USD 144.75	0.19%	United States
4	AbbVie Inc. 4 ABBV	USD 15.62 B	Sept. 30, 2024	USD 175.55	-0.67%	United States
5	Merck & Co., Inc. 5 MRK	USD 14.84 B	Sept. 30, 2024	USD 99.65	-1.32%	United States
6	Bristol-Myers Squibb Company 6 BMY	USD 13.80 B	Sept. 30, 2024	USD 55.74	0.69%	United States
7	UnitedHealth Group Incorporated 7 UNH	USD 13.10 B	Sept. 30, 2024	USD 543.74	0.48%	United States
8	Gilead Sciences, Inc. 8 GILD	USD 9.43 B	Sept. 30, 2024	USD 91.00	1.18%	United States
9	Pfizer Inc. 9 PFE	USD 8.23 B	Sept. 29, 2024	USD 26.41	-1.46%	United States
10	Thermo Fisher Scientific Inc. 10 TMO	USD 7.78 B	Sept. 28, 2024	USD 556.99	0.27%	United States
11	Abbott Laboratories 11 ABT	USD 6.49 B	Sept. 30, 2024	USD 113.02	-0.15%	United States
12	Amgen Inc. 12 AMGN	USD 6.28 B	Sept. 30, 2024	USD 267.10	-1.14%	United States
13	Cigna Corporation 13 CI	USD 5.18 B	Sept. 30, 2024	USD 285.03	0.91%	United States
14	Danaher Corporation 14 DHR	USD 5.01 B	Sept. 27, 2024	USD 237.62	-0.94%	United States
15	McKesson Corporation 15 MCK	USD 4.70 B	Sept. 30, 2024	USD 593.73	1.48%	United States
16	Colgate-Palmolive Company 16 CL	USD 3.40 B	Sept. 30, 2024	USD 87.67	0.65%	United States
17	Regeneron Pharmaceuticals, Inc. 17 REGN	USD 3.38 B	Sept. 30, 2024	USD 690.87	-3.63%	United States
18	Becton, Dickinson and Company 18 BDX	USD 3.07 B	Sept. 30, 2024	USD 235.80	-0.17%	United States
19	Cencora 19 COR	USD 3.00 B	Sept. 30, 2024	USD 240.05	1.68%	United States
20	Tenet Healthcare Corporation 20 THC	USD 2.39 B	Sept. 30, 2024	USD 127.63	-1.27%	United States
21	Zoetis Inc. 21 ZTS	USD 2.31 B	Sept. 30, 2024	USD 164.41	-1.15%	United States
22	Boston Scientific Corporation 22 BSX	USD 1.97 B	Sept. 30, 2024	USD 95.65	1.10%	United States
23	IQVIA Holdings Inc. 23 IQV	USD 1.96 B	Sept. 30, 2024	USD 197.96	-3.26%	United States
24	Viatris Inc. 24 VTRS	USD 1.91 B	Sept. 30, 2024	USD 11.72	-0.68%	United States
25	Royalty Pharma plc 25 RPRX	USD 1.80 B	Sept. 30, 2024	USD 30.03	0.13%	United States
26	Biogen Inc. 26 BIIB	USD 1.77 B	Sept. 30, 2024	USD 143.06	-4.74%	United States
27	GE HealthCare Technologies Inc. 27 GEHC	USD 1.70 B	Sept. 30, 2024	USD 84.13	-1.40%	United States
28	CVS Health Corporation 28 CVS	USD 1.69 B	Sept. 30, 2024	USD 51.57	0.10%	United States
29	DaVita Inc. 29 DVA	USD 1.42 B	Sept. 30, 2024	USD 162.00	3.15%	United States
30	Agilent Technologies, Inc. 30 A	USD 1.37 B	Oct. 31, 2024	USD 143.43	1.04%	United States
31	ResMed Inc. 31 RMD	USD 1.35 B	Sept. 30, 2024	USD 228.83	-0.62%	United States
32	Solventum Corporation 32 SOLV	USD 1.17 B	Sept. 30, 2024	USD 70.19	2.45%	United States
33	Zimmer Biomet Holdings, Inc. 33 ZBH	USD 1.16 B	Sept. 30, 2024	USD 104.71	-0.74%	United States
34	Hologic, Inc. 34 HOLX	USD 1.15 B	Sept. 28, 2024	USD 70.20	-0.13%	United States
35	Cardinal Health, Inc. 35 CAH	USD 1.06 B	Sept. 30, 2024	USD 124.03	2.62%	United States
36	Quest Diagnostics Incorporated 36 DGX	USD 1.02 B	Sept. 30, 2024	USD 152.98	-0.19%	United States
37	Oscar Health, Inc. 37 OSCR	USD 901.06 M	Sept. 30, 2024	USD 14.93	5.36%	United States
38	United Therapeutics Corporation 38 UTHR	USD 898.10 M	Sept. 30, 2024	USD 364.70	0.50%	United States
39	Laboratory Corporation of America Holdings 39 LH	USD 843.20 M	Sept. 30, 2024	USD 234.50	0.17%	United States
40	IDEXX Laboratories, Inc. 40 IDXX	USD 792.60 M	Sept. 30, 2024	USD 418.63	-0.94%	United States
41	Avantor, Inc. 41 AVTR	USD 747.20 M	Sept. 30, 2024	USD 21.72	-1.36%	United States
42	Organon & Co. 42 OGN	USD 696.00 M	Sept. 30, 2024	USD 15.81	0.96%	United States
43	Waters Corporation 43 WAT	USD 620.14 M	Sept. 28, 2024	USD 404.93	1.26%	United States
44	Revvity, Inc. 44 RVTY	USD 564.37 M	Sept. 29, 2024	USD 120.73	-1.61%	United States
45	Charles River Laboratories International, Inc. 45 CRL	USD 560.48 M	Sept. 28, 2024	USD 178.08	-6.34%	United States
46	Baxter International Inc. 46 BAX	USD 556.00 M	Sept. 30, 2024	USD 30.62	0.39%	United States
47	Medpace Holdings, Inc. 47 MEDP	USD 535.65 M	Sept. 30, 2024	USD 330.91	-5.99%	United States
48	DexCom, Inc. 48 DXCM	USD 535.00 M	Sept. 30, 2024	USD 79.17	-0.84%	United States
49	Edwards Lifesciences Corporation 49 EW	USD 502.20 M	Sept. 30, 2024	USD 71.04	-0.07%	United States
50	Lantheus Holdings, Inc. 50 LNTH	USD 451.98 M	Sept. 30, 2024	USD 92.62	-2.15%	United States

1 2 3 4 … 13

Frequently Asked Questions

Which Pharmaceuticals company in United States has the highest Free Cash Flow ?

The Pharmaceuticals company in United States with the highest Free Cash Flow is Coherent, Inc. (NYSE: COHR) at USD 61.06 B.
Which Pharmaceuticals company in United States has the lowest Free Cash Flow ?

The Pharmaceuticals company in United States with the lowest Free Cash Flow is Inovio Pharmaceuticals, Inc. (NasdaqCM: INO) at USD -84.44 B.

What are the top 10 Pharmaceuticals companies in United States by Free Cash Flow ?

The top 10 Pharmaceuticals companies in United States by Free Cash Flow are Coherent, Inc., Nutex Health, Inc., Johnson & Johnson, AbbVie Inc., Merck & Co., Inc., Bristol-Myers Squibb Company, UnitedHealth Group Incorporated, Gilead Sciences, Inc., Pfizer Inc. and Thermo Fisher Scientific Inc..
What are the bottom 10 Pharmaceuticals companies in United States by Free Cash Flow ?

The bottom 10 Pharmaceuticals companies in United States by Free Cash Flow are Inovio Pharmaceuticals, Inc., Humana Inc., Moderna, Inc., Eli Lilly and Company, Albemarle Corporation, Vertex Pharmaceuticals Incorporated, Patterson Companies, Inc., The Chemours Company, Insmed Incorporated and Vaxcyte, Inc..